{"disease":{"id":"placebo-group","name":"placebo group"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03891095","title":"Oxytocin and Dopamine's Effect on Vicarious Optimism","phase":"NA","overall_status":"COMPLETED","enrollment_count":156,"lead_sponsor_name":"Beijing Normal University","has_results":false},{"nct_id":"NCT06007014","title":"Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes","phase":"NA","overall_status":"UNKNOWN","enrollment_count":128,"lead_sponsor_name":"Yanbing Li","has_results":false},{"nct_id":"NCT06533137","title":"\"How Awareness and Subjectivity Modulate the Placebo Effect\"","phase":"NA","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Fondazione Don Carlo Gnocchi Onlus","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}